We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$26.8B
AUM Growth
+$3.09B
Cap. Flow
+$1.26B
Cap. Flow %
4.69%
Top 10 Hldgs %
40.07%
Holding
1,108
New
38
Increased
406
Reduced
634
Closed
28

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$209M
2
MCHP icon
Microchip Technology
MCHP
+$129M
3
ADI icon
Analog Devices
ADI
+$119M
4
QCOM icon
Qualcomm
QCOM
+$112M
5
TXN icon
Texas Instruments
TXN
+$108M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$309M
2
NVDA icon
NVIDIA
NVDA
+$93.3M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$78.6M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$69.7M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$35M

Sector Composition

Rank Sector Weight
1 Technology 47.45%
2 Financials 9.33%
3 Healthcare 6.2%
4 Consumer Discretionary 3.62%
5 Energy 2.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
301
Altimmune
ALT
$583M
$8.99M 0.03%
+882,628
New +$8.98M
VCEL icon
302
Vericel Corp
VCEL
$2.36B
$8.97M 0.03%
172,363
+66,549
+63% +$2.92M
INSM icon
303
Insmed
INSM
$21.3B
$8.94M 0.03%
329,635
+8,548
+3% +$239K
HALO icon
304
Halozyme
HALO
$9.76B
$8.94M 0.03%
219,752
-4,972
-2% -$186K
WTFC icon
305
Wintrust Financial
WTFC
$10.9B
$8.93M 0.03%
85,510
-1,783
-2% -$172K
DNLI icon
306
Denali Therapeutics
DNLI
$3.67B
$8.92M 0.03%
434,909
+112,936
+35% +$2.12M
NTLA icon
307
Intellia Therapeutics
NTLA
$1.5B
$8.9M 0.03%
323,561
-5,437
-2% -$151K
KEYS icon
308
Keysight
KEYS
$55B
$8.9M 0.03%
56,916
+1,410
+3% +$217K
DE icon
309
Deere & Co
DE
$163B
$8.89M 0.03%
21,652
-814
-4% -$312K
SNDX icon
310
Syndax Pharmaceuticals
SNDX
$1.7B
$8.88M 0.03%
373,238
-30,143
-7% -$672K
RXRX icon
311
Recursion Pharmaceuticals
RXRX
$1.69B
$8.88M 0.03%
890,239
-199,934
-18% -$2.23M
IRWD icon
312
Ironwood Pharmaceuticals
IRWD
$728M
$8.87M 0.03%
1,017,819
+316,049
+45% +$3.84M
RCKT icon
313
Rocket Pharmaceuticals
RCKT
$372M
$8.86M 0.03%
329,043
+120,538
+58% +$3.42M
SWTX
314
DELISTED
SpringWorks Therapeutics
SWTX
$8.84M 0.03%
179,566
+35,219
+24% +$1.63M
IDYA icon
315
IDEAYA Biosciences
IDYA
$3.41B
$8.83M 0.03%
201,291
+7,935
+4% +$341K
ACLX
316
DELISTED
Arcellx
ACLX
$8.82M 0.03%
126,751
+14,799
+13% +$938K
FOLD
317
DELISTED
Amicus Therapeutics
FOLD
$8.78M 0.03%
745,574
-49,777
-6% -$637K
APLS
318
DELISTED
Apellis Pharmaceuticals
APLS
$8.75M 0.03%
148,801
+5,683
+4% +$362K
UTHR icon
319
United Therapeutics
UTHR
$25.7B
$8.67M 0.03%
37,730
+584
+2% +$132K
DVAX
320
DELISTED
Dynavax Technologies
DVAX
$8.66M 0.03%
697,907
+157,588
+29% +$2.06M
IOVA icon
321
Iovance Biotherapeutics
IOVA
$1.93B
$8.66M 0.03%
584,111
-663,404
-53% -$7.72M
BHVN icon
322
Biohaven
BHVN
$2.01B
$8.65M 0.03%
158,192
-113,385
-42% -$5.61M
PCVX icon
323
Vaxcyte
PCVX
$7.73B
$8.62M 0.03%
126,164
-32,249
-20% -$2.23M
HPQ icon
324
HP
HPQ
$24.8B
$8.59M 0.03%
284,145
+12,295
+5% +$362K
DUK icon
325
Duke Energy
DUK
$96.9B
$8.58M 0.03%
88,724
+2,745
+3% +$260K
11 12
13
14 15

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Rafferty Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Rafferty Asset Management held 1,108 positions worth $26.8B, up 13% from $23.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rafferty Asset Management deployed $1.26B of net new capital in Q1 2024, opening 38 new positions and adding to 406 existing holdings. Its largest new stake was Super Micro Computer: 164,060 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 40% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $309M trimmed.

  • Rafferty Asset Management's largest Q1 2024 buy was Super Micro Computer: 164,060 shares worth $16.6M.
  • Rafferty Asset Management added most to Intel in Q1 2024, an estimated $209M increase.
  • Rafferty Asset Management's biggest Q1 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $309M.
  • Rafferty Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $13.8M.
  • Rafferty Asset Management's ten largest holdings make up 40% of its $26.8B portfolio in Q1 2024.
  • Rafferty Asset Management opened 38 new positions and closed 28 in Q1 2024.
  • Rafferty Asset Management's portfolio value rose 13% quarter-over-quarter to $26.8B.

Based on Rafferty Asset Management's 13F filing for Q1 2024, filed 13 May 2024.